Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

3.1K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.1K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

10.2K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.2K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

4.1K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
4.1K
Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers01:25

Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers

1.6K
β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but...
1.6K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

2.5K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.5K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

1.6K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Empirical comparison of health-related quality of life and subjective well-being measures in Australian adolescents.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026
Same author

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same author

Measuring inequality in quality of life: further evidence that the EQ-5D-5L may underestimate it.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026
Same author

Beyond aldosterone and renin: emerging biomarkers for diagnosing and subtyping primary aldosteronism.

Endocrine reviews·2026
Same author

Prevalence, clinical characteristics and management of low-renin hypertension: a real-world cohort study.

Journal of human hypertension·2026
Same author

Health Watch: cancer and mortality update in a 40-year prospective cohort study of Australian petroleum workers.

Occupational and environmental medicine·2026

Related Experiment Video

Updated: Mar 3, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

24.4K

Preferences for Subtyping Primary Aldosteronism: A Discrete Choice Experiment.

Maame Esi Woode1,2, Winston Chong3,4, Elisabeth Ng5

  • 1Centre for Health Economics, Monash Business School, Monash University, Caulfield East, VIC 3145, Australia.

Journal of the Endocrine Society
|March 2, 2026
PubMed
Summary
This summary is machine-generated.

Hypertension patients prefer less invasive, faster, and cheaper primary aldosteronism (PA) subtyping methods. Accuracy is key, but cost and waiting time significantly influence choices for diagnosing unilateral vs. bilateral PA.

Keywords:
PET-CTadrenal vein samplinghypertensionpredictive algorithmprimary aldosteronismsubtyping

More Related Videos

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
13:20

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance

Published on: December 5, 2025

1.1K
Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

12.5K

Related Experiment Videos

Last Updated: Mar 3, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

24.4K
Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
13:20

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance

Published on: December 5, 2025

1.1K
Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

12.5K

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Health Economics

Background:

  • Primary aldosteronism (PA) affects 10-15% of hypertensive individuals, increasing cardiovascular risk.
  • Accurate differentiation between unilateral and bilateral PA is crucial for optimal treatment, often necessitating adrenal vein sampling (AVS).
  • Emerging subtyping strategies include predictive algorithms and nuclear imaging, offering potential alternatives to AVS.

Purpose of the Study:

  • To investigate the preferences of hypertensive individuals regarding different primary aldosteronism (PA) subtyping strategies.
  • To understand patient priorities concerning test accuracy, waiting time, adverse effects, and out-of-pocket costs for PA diagnosis.

Main Methods:

  • Two discrete choice experiments (DCEs) were employed to assess preferences for PA subtyping methods.
  • Latent class conditional logit (LCL) modeling was used to segment participants based on preferences.
  • Policy simulation analyses examined how age, sex, and income influence subtyping uptake.

Main Results:

  • 85% of 583 hypertensive Australian adults were willing to undergo PA subtyping.
  • Participants prioritized accuracy, followed by shorter waiting times, minimal adverse effects, and lower costs.
  • Algorithm-based methods showed the highest initial uptake (~54%), increasing to 68% when cost was considered.

Conclusions:

  • Patient preferences for PA subtyping are significantly influenced by cost, invasiveness, and waiting time.
  • Less-invasive, faster, and low-cost methods are favored, even with slightly lower accuracy than AVS.
  • Further research should focus on optimizing algorithm accuracy and clinical implementation of preferred subtyping methods.